Back to search results

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Abroad (travel likely)RecruitingPHASE2

Conditions

Human Immunodeficiency Virus (HIV) Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Colorado at Denver ( Site 0108), Aurora, Colorado, United States

  • Emory Children's Center ( Site 0103), Atlanta, Georgia, United States

    Study coordinator · 404-727-5642

  • Clinica Somer ( Site 1003), Rionegro, Antioquia, Colombia

    Study coordinator · +573235903405

  • Ciensalud Ips S A S ( Site 1001), Barranquilla, Atlántico, Colombia

    Study coordinator · 573183894721

  • CEIP - Centro de Estudios en Infectología Pediátrica ( Site 1002), Cali, Valle del Cauca Department, Colombia

  • Instituto Nacional de Pediatria ( Site 0701), Coyoacán, Mexico City, Mexico

  • Hospital Infantil de Mexico Federico Gomez ( Site 0702), Mexico City, Mexico City, Mexico

  • Unidad de Atencion Medica e Investigacion en Salud S.C. ( Site 0700), Mérida, Yucatán, Mexico

  • Kuzbasskiy Center for the Prevention and Control of AIDS ( Site 0506), Kemerovo, Kemerovo Oblast, Russia

  • Clinical Centre for Prevention and Control of AIDS ( Site 0504), Krasnodar, Krasnodarskiy Kray, Russia

  • Krasnoyarsk Regional Center for Prevention and Control of AIDS ( Site 0507), Krasnoyarsk, Krasnoyarsk Krai, Russia

  • Infectious Clinical Hospital #2 ( Site 0501), Moscow, Moscow, Russia

  • FGU Republican Clinical Infectious Hospital of Roszdrav ( Site 0500), Saint Petersburg, Sankt-Peterburg, Russia

  • FARMOVS PTY LTD ( Site 0601), Bloemfontein, Free State, South Africa

  • Perinatal HIV Research Unit ( Site 0602), Johannesburg, Gauteng, South Africa

    Study coordinator · +2711 989 9700

  • Wits Reproductive Health and HIV Institute (WRHI) ( Site 0603), Johannesburg, Gauteng, South Africa

    Study coordinator · +27 11 358 5300

  • Empilweni Services and Research Unit ( Site 0604), Johannesburg, Gauteng, South Africa

  • King Edward Hospital ( Site 0600), Durban, KwaZulu-Natal, South Africa

    Study coordinator · +27312611093

  • Family Clinic Research With UBUNTU ( Site 0605), Cape Town, Western Cape, South Africa

    Study coordinator · +27219384153

  • Be Part Yoluntu Centre ( Site 0606), Paarl, Western Cape, South Africa

    Study coordinator · +2782 660 5795

  • Tsitsikamma Clinical Research Initiative (TCRI) ( Site 0607), Plettenberg Bay, Western Cape, South Africa

  • Siriraj Hospital ( Site 0901), Bangkok, Bangkok, Thailand

    Study coordinator · +6624180545

  • Research Institute for Health Sciences ( Site 0902), Chiang Mai, Thailand

    Study coordinator · +6653936148

  • Faculty of Medicine - Khon Kaen University ( Site 0903), Khon Kaen, Thailand

    Study coordinator · +66897112236
Study leads

  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC

View source on ClinicalTrials.gov(opens in a new tab)